Martin T. Permin

Yo, have you heard of Martin T. Permin? Dude’s a total beast in the startup world. He’s part of YC W22, so he’s fresh off the line, but don’t let that fool you, this guy’s been around the block more times than most. His resume? It’s stacked. He’s been with Airbnb, Pelion, Hive.co, and he even co-founded Invert. Basically, he’s seen what works and what doesn’t from a bunch of angles.

What’s crazy is his latest hustle, he’s all about transforming biomanufacturing using software. I mean, what? Yeah, he’s into biotech now, but he’s not just tinkering in some lab. He’s out here trying to make biotech production way more fast and accessible, leveraging software to shake up an industry that’s been slow and stuck in the past. That’s some advanced thinking, right? It’s clear he’s not just in it for a quick buck; he’s genuinely solving real problems and pushing industries forward.

Digging into his story, it’s clear that this dude’s driven by more than just startups, he’s got a real curiosity, a hunger to innovate and disrupt. His experience at Airbnb and Pelion, and even his multiple stints with YC, tell me he’s not afraid to jump into the deep end, learn fast, and iterate like crazy. He’s not about bullshit; he’s about results. The fact that he’s done YC twice, yeah, twice, shows he’s resilient as hell. Some founders get knocked down, but Martin? He just keeps bouncing back, learning from each experience, and leveling up.

What his process says about him? He’s all-in on making a difference. He sees the big picture, not just the next exit. His work in biotech and his background in tech shows he’s got a passion for building stuff that actually matters. And he’s not just following trends; he’s creating the future. That’s why he’s so interesting, he’s the real deal, someone who’s pushing boundaries and not settling for bullshit.

So, in a nutshell, Martin Permin is a visionary techie turned biotech innovator. He’s someone who’s crushed it in the startup game, learned from the best, and now is on a mission to change how we make medicine and biotech stuff through software. No cap, this guy’s a big change, and I’m sure we’ll see a lot more from him in the next few years.